 L. Patients who require hematopoietic growth factor support e.g. epogen, darbepoetin, but not myeloid growth factors except after cycle 1 day 1 if clinically indicated, non-steroidal anti-inflammatory drug NSAIDs, and other maintenance medications prior to study entry will be allowed to continue their supportive therapies. 